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Graft-versus-host disease(GVHD) in man and animals is associated with immune
dysfunction, which results in significant morbidity and mortality (1). However, the
precise role of graft-versus-host (GVH) reactivity in producing immune dysfunc-
tion is difficult to evaluate, because ablation of host immunity is necessary before
GVHD can be induced. Examination of the effects of GVH reactions without
reciprocal reactions ofhost aganist donor have involved the use of recipients that
are not immunocompetent, such as neonatal mice (2), and adult animals in which
the immune system has been artificially ablated by lethal or sublethal irradiation
(3-6). In addition, GVH reactionshave been induced in recipients that are initially
immunocompetent but specifically tolerant ofdonor inocula. For example, GVHD
has been induced by injection ofdonor lymphocytes into adult rodents neonatally
tolerized to donor antigen (7, 8), and the effects ofGVH inocula on immune func-
tion have been extensively studied in immunocompetent F1 animals inoculated with
parental lymphocytes (9-13). Loss of immune responsiveness after inoculation of
Fl recipients with parental lymphocytes has been variably attributed to suppressor
cells (9-11), destruction of recipient lymphocytes (11, 14, 15), and thymic injury (9,
12, 13). However, the contribution ofeach of these mechanisms has not been well
defined. We have now studied the effects ofGVH reactions on immune responsive-
ness inanimals with otherwiseintact immune systems, inwhich toleranceofrecipients
to the donor inoculum is not due to a genetic mechanism, but has instead been in-
duced by lethal irradiation followed by reconstitution with T cell-depleted (TCD)
bone marrow (BM). Comparison of the effects ofGVH inocula in fully allogeneic
vs. mixed allogeneic chimeras as well as examination ofthe effects ofhost vs. graft
(HVG) inocula have allowedexaminationoftheroleofrecipientlymphohematopoietic
cells, in distinction from the remainder of the animal's tissues, in inducing the im-
mune abnormalities associated with GVH reactions in vivo.
Materials and Methods
Radiation bone marrow chimeras were prepared as previously described (16, 17). Briefly,
recipient C57BL/10SnJ (B10) or Bl0.D2nSn (B10.D2) mice, 12-14 wk old, received lethal whole
body irradiation and were reconstituted with allogeneic (B10 or B10.D2) with or without syn-
geneic (recipient strain) TCD bone marrow. Appropriate levels of chimerism were ascer-
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tained in allchimeric responders by H-2 phenotypingof PBL by fluorescence microfluorim-
etry performed 6-10 wk after bone marrow transplantation (BMT) (18). Animals receiving
5 x 106 TCD syngeneic plus 1.5 x 10' TCD allogeneic BM cells reconstituted as stable
mixed chimeras, demonstrating 25-75°Jo allogeneic lymphoid chimerism, and are referred
to here as "mixed" chimeras. Animals reconstituted with 1.5 x 107 TCDallogeneic cells alone
aredesignated "allogeneic" chimeras anddemonstrated 94-99% allogeneic chimerism. Previous
studieshave established thepresence ofspecific tolerance to donorand host antigen and per-
manent, stable chimerism in such animals (16, 17). GVH inocula consisting of 2-3 x 107
splenocytes from normal donor-strain mice were administered viathe lateral tail vein 10-22
wk after BMT Theserecipients, as well as uninjected controlchimeras, were killed 12 d after
inoculation, and cell-mediated lympholysis (CML) responses of their splenocytes were as-
sessed as previously described (19).
Results and Discussion
GVH inocula consisting of 2-3 x 10' splenocytes from normal donor-strain mice
were administered to long-term stable chimeras. Fig. 1 (upper panels) shows typical
CML responses of along-term B10 + B10.D2 -" B10 mixed allogeneic chimera 12
d afterinoculation with B10.D2 splenocytes. The uninjected animal was unrespon-
sive to donor (B10.D2) and host (1310) antigen, but responded normally to third-
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FIGURE 1.
￿
Cell-mediatedlympholysis (CML) responsesofchimeras against (A)host (1310), (B)
donor (B10.D2), and (C) third-party (B10.BR) alloantigen 12 d after inoculation with normal
donor-strain (BIO.D2) spleen cells(EI) or in unmanipulatedcontrol chimeras (O). Positive con-
trol responses (/) of normal (A) B10.D2 or (B) B10 spleen cells as well as negative control re-
sponses (") ofnormal (A) B10, (B) B10.D2, or (C) B10.BR spleen cells are also shown. Irradiated
stimulator cells andtarget blasts (stimulated with ConA for 2 d in culture) were obtained from
normal B10 mice in A, from B10.D2 mice in B, and from B10.BR mice in C. Upper panels show
responses of mixed chimeras (1310 + B10.D2 - B10), andlower panels show responses ofan al-
logeneic chimeras (B10.D2 - B10) given an identical B10.D2 spleen cell inoculum at the same
time, as well as those of an unmanipulated allogeneic chimera.SYKES ET AL.
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party(B10.BR) alloantigen . Theinjected chimera, in contrast,was severely hyporespon-
sive towards third-party alloantigen . Similar anti-third-partyCMLhyporesponsiveness
has been observed in 17 of 17 mixed chimeras tested from 10 to 28 d after adminis-
tration ofGVH inocula . Anti-third-party alloresponsiveness was lost between 5 and
10 d after inoculation, and recovered in most animals by 7-12 wk (data not shown) .
Similar to uninjected control chimeras, the injected mixed chimera shown in Fig.
1 was unresponsive todonorantigen . It did, however, demonstrate slightCML reac-
tivity towards host antigen, which was a common but variable finding among in-
jected mixed chimeras .
Alloresponses were studied in 1310.132- B10 (allogeneic) chimeras after adminis-
tration of similar GVH inocula, and compared with those of allogeneic chimeras
not receiving GVH inocula . Unlike mixed chimeras given identical inocula in the
same experiments, allogeneic chimeras retainedCML responsiveness to third-party
alloantigen (Fig. 1 C, lower panel) . Such responsiveness was maintained at all time
points tested (5, 10, 12, 13, 21, and 28 d afterGVH inoculum) . Injected allogeneic
chimeras also remained unresponsive to donor antigen, and some demonstrated slight
CML reactivity towards host antigen .
Therefore, these studies demonstrated that mixedchimeras, when inoculated with
nontolerant donor-strain cells, lost the ability to generateCTL in response to third-
party alloantigen . These results are similar to those described in Fl recipients, in
which administration of parental cells recognizing Fl class I plus class II alloantigens
results in loss ofCML responses to third-party alloantigen (10, 11, 14, 20). In con-
trast, when donor-strain lymphocytes were injected into allogeneic chimeras, CML
responses ofrecipient chimeras to third-partyalloantigenwere not significantly affected .
These findings suggested that the development ofGVH-related immunodeficiency
might depend on the presence of substantial numbersoflymphohematopoietic cells
expressing the recipient phenotype, and that therecognition of such antigenon other
somatic cells of thehost was not sufficient to induce immunodeficiency. We reasoned
that ifthis were true, then thepresence ofaone-way response to donor-type lympho-
hematopoietic cells might also be sufficient to lead to immune hyporesponsiveness,
in this case induced by administration of nontolerant recipient-strain lymphocytes
to mixed chimeras (i.e., HVG inocula) . Such mixed chimeras would provide donor
BM-derived lymphohematopoietic cells as asource of stimulatingantigen, and should
be tolerant of recipient antigen (16, 17), and therefore, should not react against in-
jected recpient-strain lymphocytes .
To test this hypothesis, 3 x 10' recipient-strain splenocytes were injected into
long-term B10 + 1310.132 -" B10 and B10 + B10.D2 - B10.D2 mixed chimeras . As
a control, additional mixed chimeras of both types received GVH inocula (3 x 10'
donor-strain, B10 or B10.D2 splenocytes) in the same experiment . Representative
anti-third-party alloresponses from such animals 12 d after inoculation are shown
in Fig . 2 . Injection ofeither B10or B10.D2 splenocytes into mixed chimeras of either
1310 or 1310.132 recipient strains resulted inmarked hyporesponsiveness to third-party
alloantigen, irrespective of whether the splenocytes represented aGVH or an HVG
inoculum . Uninjected control animals, in contrast, remained responsive to third-
party alloantigen . Thus, the presence of a one-way alloresponse to either donor or
host antigen on lymphohematopoietic cells in vivo was sufficient to induce hyporespon-
siveness to third-party alloantigen, indicating that induction of unresponsiveness does
not specifically require aGVH reaction . It therefore seems likely that induction of
GVH-related immunodeficiency described in parent into Fi systems (9-12, 15, 20)2394
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EffectsofGVHandHVG
inocula on anti-third-party CMLre-
sponses in mixedallogeneic chimeras.
Splenocytes were removedfrom mixed
B10 + B10.D2 - B10 (left paneo and
B10 + B10.D2 - B10.D2 (right paneo
chimeras 13 d after inoculation with
B10 (") or B10.D2 (O) lymphocytes,
or afterno injection ("). Curves rep-
resent percent specific lysis at various
responder/target ratios of chimeric
splenocytes on B10.BR Con A blasts
afterincubation for5dwith irradiated
B10.BR stimulator cells(see legend to
Fig. 1). Similar resultswere obtained
in three independent experiments.
might not require a generalized GVH reaction, but instead might reflect a one-way
immune response in vivo to host lymphohematopoietic components.
These results are incompatible with one possible explanation for the immune dys-
function observed in F1 animals inoculated with parental lymphocytes, namely the
destruction of recipient T cells by the donor inoculum (11, 14) with selective over-
growth of host-reactive donor-derived T cells (15). Mixed chimeras contain T cells
derived from both donor and recipient strain BM, and preliminary data indicate
that both types of T cells are capable of mediating CTL responses (unpublished
data). Therefore, those donor- or recipient- BM-derived T cells that are capable
of mediating immune responses against third-party alloantigen but that are not poten-
tial targets of GVH- or HVG-reactive cells, respectively, should persist after GVH
or HVG inoculation. The apparent inability of these cells to respond to third-party
alloantigen suggests that they may in some way be inactivated as a result ofthe GVH
reaction. Preliminary studies suggest this may be due to the induction of a G10-
adherent suppressor cell population (Sykes et al., unpublished data).
Complete repopulation with allogeneic cells occurred in most mixed chimeras by
30-60 d after administration of GVH inocula. Although such repopulation is evi-
dence for the occurrence of antihost aggressive activity in vivo, these animals sur-
vived long-term with no clinical evidence of GVHD. The numbers of donor-strain
lymphocytes administered in GVH inocula in these experiments greatly exceeded
those required to produce lethal GVHD in fresh irradiated animals (21). It is there-
fore possible that suppressive activity producing the immune hyporesponsiveness
described here may also protect recipients from GVHD. However, tolerance to donor
alloantigen is rapidly broken in recipients ofsimilar HVG inocula to those used here
(22), indicating that the immunosuppression resulting from such inocula is not effective
in preventing the alloreactivity associated with graft rejection. Alternative explana-
tions for the absence ofGVHD in mixed chimeric recipients ofGVH inocula, there-
fore, also deserve consideration. Induction of clinical GVHD may require factors
in addition to one-way immune responses against host lymphohematopoietic cells
in vivo, such as the acute tissue injury and infections that may follow lethal irradia-
tion (9). It is also possible that a form of alloresistance against donor lymphoid cells
exists in mixed chimeras similar to that which protects FI mice from the induction
of GVH-related effects by parental lymphocytes of certain strains (20).
In summary, the studies presented here suggest a requirement for lympho-
hematopoietic cellsbearing host antigen in the induction ofGVH-related immunosup-We thankDrs . Gene Shearerand Thor Sundt for helpful review ofthemanuscript, and Mrs.
JudyJaworek for expert secretarial assistance . We also thankMr. Donald Holt and his staff
for excellent animal care.
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pression in radiation chimeras . A similar defect in immune responses was found
inmixed chimeras given inocula that attack donorand not recipient antigens . These
findings are most consistent with the interpretation that the immunodeficiency as-
sociated with GVH reactions is due to the development of suppressive activity as
aconsequenceofastrong one-way alloresponse directed against lymphohematopoietic
cells in vivo, whether this be an HVG or a GVH response. The presence of such
immune suppression in mixed chimeras did not lead to death from infection, and
did not appear to prevent the rapid loss of tolerance to donor antigen in animals
givenHVG inocula(22) . The apparent discrepancy between thetolerance-breaking
studies (22) and those reported here might either be due to differences in the time
courses of the in vitro and in vivo phenomena, or might indicate that in vitro un-
responsiveness does not accurately reflect the in vivo immune status of such recipients .
Further studies will be required to elucidate the in vivo consequences, if any, of the
immune unresponsiveness observed in vitro afteradministration ofHVGandGVH
inocula. One potential consequence to be addressed is the possibility that in vivo
reactivity against injected lymphohematopoietic cells is responsible forthe nonspecific
immunosuppression that appears to result afterblood transfusion in prospective organ
transplant recipients (23) .
Summary
Graft-vs.-host (GVH)-related immunosuppression has previously been demon-
strated in Fl rodent recipients of parental lymphoid cells, and has been thought to
result from an immunologic attack of the donor against the host . Since all cells of
such Ft recipients could potentially bear target class IMHC alloantigens, it has not
previously been possible to determine precisely the target tissues responsible forde-
velopment ofGVH-related effects . In the present studies we have used mixed al-
logeneic chimeras as recipients of host or donor-strain lymphocyte inocula, andhave
made the surprising observation that "GVH-induced" immune unresponsiveness does
not require GVH reactivity, per se, but develops in the presence of a one-way al-
loresponse against lymphohematopoietic cells in either theGVH or the host-versus-
graft direction .
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